Beat AML Master Trial: A Groundbreaking Clinical Trial for Acute Myeloid Leukemia Patients Milestones in Acute Myeloid Leukemia
Cancers | Free Full-Text | New Therapeutic Strategies for Adult Acute Myeloid Leukemia
The Leukemia & Lymphoma Society Launches Groundbreaking Precision Medicine Approach to Treat Acute Myeloid Leukemia, One of the Deadliest Blood Cancers
The Leukemia & Lymphoma Society Launches Groundbreaking Precision Medicine Approach to Treat Acute Myeloid Leukemia, One of the Deadliest Blood Cancers
Beat AML Master Trial: A Groundbreaking Clinical Trial for Acute Myeloid Leukemia Patients
Acute Myeloid Leukemia Clinical Research | OSUCCC – James
The Leukemia & Lymphoma Society Launches Groundbreaking Precision Medicine Approach to Treat Acute Myeloid Leukemia, One of the Deadliest Blood Cancers
Frontiers | Comprehensive analysis of ECHDC3 as a potential biomarker and therapeutic target for acute myeloid leukemia: Bioinformatic analysis and experimental verification
Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial | Nature Medicine
Beat AML Master Trial Media Toolkit | Leukemia and Lymphoma Society
Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial | Nature Medicine
Beat AML
Heterogeneity in refractory acute myeloid leukemia | PNAS
Fighting a formidable leukemia with an expansive clinical trial | Cancer Translated
Beat AML study paves way for precision treatment | Cancer Translated
A cellular hierarchy framework for understanding heterogeneity and predicting drug response in AML | bioRxiv
Beat AML Master Trial Media Toolkit | Leukemia and Lymphoma Society
Beat AML Master Trial Media Toolkit | Leukemia and Lymphoma Society
What is the Beat AML Master Clinical Trial? - YouTube
Acute myeloid leukemia: 2019 update on risk‐stratification and management - Estey - 2018 - American Journal of Hematology - Wiley Online Library
Bringing Precision Medicine to AML Patients | Leukemia and Lymphoma Society
Study Shows Acute Myeloid Leukemia Patients Who Participated in Upfront Genomic Testing Had Superior Treatment and Survival Outcomes
Bipartite network models to design combination therapies in acute myeloid leukaemia | Nature Communications
AML Hub on Twitter: "Eytan Stein from @sloan_kettering presents data from the #BeatAML trial at #ASH18 #AML #leusm #leukemia @LLSusa https://t.co/65YjaMp9JS" / Twitter
Beat AML figures
